This preclinical study characterized the temporal progression of retinal degeneration in Pde6b rd1/rd1 mice from birth through P14 and found that early oral idebenone treatment at P14 extended photoreceptor survival and enhanced retinal synaptogenesis, while late treatment at P21 showed no benefit.